Boosting immune response to hepatitis B DNA vaccine by coadministration of prothymosin α-expressing plasmid

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 12, 2005, Pages 1364-1369

  Jin, Yanwen ^a   Cao, Cheng ^a   Li, Ping ^a   Liu, Xuan ^a   Huang, Wei ^a   Li, Chufang ^a   Ma, Qingjun ^a,b  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; DNA VACCINE PRES2S; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PROTHYMOSIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE MODEL; DNA DETERMINATION; DRUG POTENCY; FEMALE; HEPATITIS B; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; PROTEIN PRECURSORS; T-LYMPHOCYTES; THYMOSIN; VACCINES, DNA;

EID: 29144478420     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.12.1364-1369.2005     Document Type: Article

References (49)

1. Ando, K., L. G. Guídotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
2. Baxevanis, C. N., A. D. Gritzapis, G. V. Z. Dedoussis, N. G. Papadopoulos, O. Tsolas, and M. Papamichail. 1994. Induction of lymphokine-activated killer activity in mice by prothymosin alpha. Cancer Immunol. Immunother. 38:281-286.
3. Baxevanis, C. N., A. D. Gritzapis, G. Spanakos, O. K. Tsitsilonis, and M. Papamichail. 1995. Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha. Cancer Immunol. Immunother. 40:410-418.
4. Borgne, S. L., M. Mancini, R. L. Grand, M. Schleef, D. Dormont, P. Tiollais, Y. Riviere, and M.-L. Michel. 1998. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240:304-315.
5. Bourne, N., L. R. Stanberry, D. I. Bernstein, and D. Lew. 1996. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:800-807.
6. Boyer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. V. Williams, Y. Refaeli, R. B. Ciccarelli, D. McCallus, L. Coney, and D. B. Weiner. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526-532.
7. Boyle, J. S., J. L. Brady, and A. M. Lew. 1998. Enhanced response to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408-411.
8. Chen, X. S., G. J. Wang, X. Cai, H. Y. Yu, and Y. P. Hu. 2001. Inhibition of hepatitis B virus by oxymatrine in vivo. World J. Gastroenterol. 7:49-52.
9. Davis, H. L., M. Mancini, M.-L. Michel, and R. G. Whalen. 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14:910-915.
10. Dentico, P., R. Buongiorno, A. Volpe, A. Zavoianni, G. Pastore, and O. Schiraldi. 1992. Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. Eur. J. Epidemiol. 8:650-655.
11. 2-d mice. Shijie Huaren Xiaohua Zazhi 8:128-130. (In Chinese.)
12. Fang, J. N., C. J. Jin, L. H. Cui, Z. Y. Quan, B. Y. Choi, M. R. Ki, and H. B. Park. 2001. A comparative study on serologic profiles of virus hepatitis B. World J. Gastroenterol. 7:107-110.
13. Geissler, M., K. Tokushige, T. Wakita, V. R. Zurawski, Jr., and J. R. Wands. 1998. Differential cellular and humoral immunization using chimeric constructs. Vaccine 16:857-867.
14. Gregoriadis, G., R. Saffie, and J. B. de Souza. 1997. Liposome-mediated DNA vaccination. FEBS Lett. 402:107-110.
15. Haritos, A. A., G. J. Goodall, and B. L. Horecker. 1984. Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha I in rat thymus. Proc. Natl. Acad. Sci. USA 81:1008-1011.
16. Haritos, A. A., R. Blacher, S. Stein, J. Caldarella, and B. L. Horecker. 1985. Primary structure of rat thymus prothymosin alpha. Proc. Natl. Acad. Sci. USA 82:343-346.
17. Haritos, A. A., S. B. Salvin, R. Blacher, S. Stein, and B. L. Horecker. 1985. Parathymosin alpha: a peptide from rat tissues with structural homology to prothymosin alpha. Proc. Natl. Acad. Sci. USA 82:1050-1053.
18. Hassett, D. E., and J. L. Whitton. 1996. DNA immunization. Trends Microbiol. 4:307-312.
19. Hoofnagle, J. H., and A. M. di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
20. Iwasaki, A., B. J. N. Stiernholm, A. K. Chan, N. L. Berinstein, and B. H. Barber. 1997. Enhanced cytotoxic T-lymphocyte responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J. Immunol. 158:4591-4601.
21. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816-826.
22. Lee, W. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733-1745.
23. Liu, H. B., Z. D. Meng, J. C. Ma, C. Q. Han, Y. L. Zhang, Z. C. Xing, Y. W. Zhang, Y. Z. Liu, and H. L. Cao. 2000. A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns. World J. Gastroenterol. 6:381-383.
24. Loirat, D., Z. Li, M. Mancini, P, Tiollais, D. Paulin, and M.-L. Michel. 1999. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology 260:74-83.
25. Low, T. L., G. B. Thurman, M. McAdoo, J. McClure, J. L. Rossio, P. H. Naylor, and A. L. Goldstein. 1979. The chemistry and biology of thymosin. I. Isolation, characterisation, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J. Biol. Chem. 254:981-986.
26. Mancini, M., M. Hadchouel, H. L. Davis, R. G. Whalen, P. Tiollais, and M.-L. Michel. 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. USA 93:12496-12501.
27. Manickan, E., R. J. D. Rouse, Z. Yu, W. S. Wire, and B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:259-265.
28. McClements, W. L., M. E. Armstrong, R. D. Keys, and M. A. Liu. 1996. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B. alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93:11414-11420.
29. Mendoza, R. B., M. J. Cantwell, and T. J. Kipps. 1997. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159:5777-5781.
30. Michel, M. L., P. Pontisso, E. Sobczak, Y. Malpiece, R. E. Streeck, and P. Tiollais. 1984. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. USA 81:7708-7712.
31. Michel, M. L., H. L. Davis, M. Sehleef, M. Mancini, P. Tiollais, and R. G. Whalen. 1995. DNA-mediated immunization of the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.
32. Michel, M. L., and D. Loirat. 2001. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B. Intervirology 44:78-87.
33. Pan, L. X., A. A. Haritos, J. Widemann, T. Komiyama, M. Chang, S. Steins, S. B. Salvin, and B. L. Horecker. 1986. Human prothymosin alpha: amino acid sequence and immunologic properties. Arch. Biochem. Biophys. 250: 197-201.
34. Panneerselvam, C., A. A. Haritos, J. Caldarella, and B. L. Horecker. 1987. Prothymosin alpha in human blood. Proc. Natl. Acad. Sci. USA 84:4465-4469.
35. Papanustasiou, M., C. N. Baxevanis, and M. Papamichail. 1992. Promotion of murine antitumor activity by prothymosin alpha treatment. I. Introduction of tumoricidal peritoneal cells producing high levels of TNF. Cancer Immunol. Immunother. 35:145-150.
36. Reyes, S. A., and H. C. Ertl. 2000. DNA vaccines. Curr. Mol. Med. 78:495-506.
37. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin- expressing plasmid DNA. Vaccine 11:957-960.
38. Sasaki, S., T. Takashi, K. Hamajima, J. Fukushima, N. Ishii, T. Kaneko, K. Q. Xin, H. Mohri, I. Aoki, T. Okubo, K. Nishioka, and K. Okuda. 1997. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:3520-3528.
39. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Cory, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
40. Tang, D. C., M. De Vit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
41. Toda, S., N. Ishii, E. Okada, K. I. Kusakabe, H. Aral, K. Hamajima, I. Gorai, K. Nishioka, and K. Okuda. 1997. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology 92:111-117.
42. Tsuji, T., J. Fukushima, K. Hamajima, N. Ishii, I. Aoki, H. Bukawa, Y. Ishigatsubo, K. Tani, M. E. Dorf, and K. Okuda. 1997. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology 90:1-6.
43. Ulmer, J. B., J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
44. Valenzuela, P., A. Medina, W. J. Rutter, G. Ammerer, and B. D. Hall. 1982. Synthesis and assembly of hepatitis B surface antigen particles in yeast. Nature 298:347-350.
45. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
46. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Ascadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
47. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.
48. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Wojczyk, and H. C. J. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209:569-579.
49. Zhao, L. S., S. Qin, T. Y. Zhou, H. Tang, L. Liu, and B. J. Lei. 2000. DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc. World J. Gastroenterol. 6:239-243.